Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-617.95%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information
Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABVC BIOPHARMA INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABVC - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -2.42M | -617.95% | $ 391.24K |
| 3/31/2025 | $ -1.24M | -244.84% | $ 508.38K |
| 12/31/2024 | $ -3.99M | -782.32% | $ 509.59K |
| 9/30/2024 | $ -5.88M | -1153.74% | $ 509.79K |
| 6/30/2024 | $ -8.01M | -5875.82% | $ 136.4K |
| 3/31/2024 | $ -9.22M | -36368.91% | $ 25.36K |
| 12/31/2023 | $ -7.74M | -5076.28% | $ 152.43K |
| 9/30/2023 | $ -9.67M | -1308.5% | $ 739.26K |
| 6/30/2023 | $ -11.15M | -1456.08% | $ 765.64K |
| 3/31/2023 | $ -11.01M | -1026.63% | $ 1.07M |
Key Performance Insights, Last 5 Years
- ABVC BIOPHARMA INC's latest trailing twelve months (TTM) EBITDA % stands at -3309.36%.
- Over the past 5 years, ABVC BIOPHARMA INC's average EBITDA % has been -5504.82%.
- The median EBITDA % for ABVC BIOPHARMA INC during this period was -1578.47%
- ABVC BIOPHARMA INC reached its highest EBITDA % over the past 5 years at -244.84%.
- The lowest EBITDA % recorded by ABVC BIOPHARMA INC in the same timeframe -36368.91%
ABVC BIOPHARMA INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ABVC BIOPHARMA INC is calculated as follows: EBITDA [ $ -11.77M ] / Revenues [ $ 355.8K ]
(=) EBITDA % [ -3309.36% ] ABVC - EBITDA Margin, Last 5 years
-36368.91%
Minimum
Mar 31, 2024
-244.84%
Maximum
Mar 31, 2025
-5504.82%
Average
-1578.47%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |